These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35098103)

  • 1. A determination of pan-pathogen antimicrobials?
    Prathapan P
    Med Drug Discov; 2022 Jun; 14():100120. PubMed ID: 35098103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-spectrum therapeutics: A new antimicrobial class.
    Firth A; Prathapan P
    Curr Res Pharmacol Drug Discov; 2021; 2():100011. PubMed ID: 34870144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics.
    Catalano A; Iacopetta D; Pellegrino M; Aquaro S; Franchini C; Sinicropi MS
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33477901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Building Blocks of Antimicrobial Resistance in
    Langendonk RF; Neill DR; Fothergill JL
    Front Cell Infect Microbiol; 2021; 11():665759. PubMed ID: 33937104
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
    Mostafa A; Kandeil A; A M M Elshaier Y; Kutkat O; Moatasim Y; Rashad AA; Shehata M; Gomaa MR; Mahrous N; Mahmoud SH; GabAllah M; Abbas H; Taweel AE; Kayed AE; Kamel MN; Sayes ME; Mahmoud DB; El-Shesheny R; Kayali G; Ali MA
    Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33291642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond Traditional Antimicrobials: A
    Kong C; Eng SA; Lim MP; Nathan S
    Front Microbiol; 2016; 7():1956. PubMed ID: 27994583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioterrorism and emerging infectious disease - antimicrobials, therapeutics and immune-modulators. SARS coronavirus.
    Shurtleff AC
    IDrugs; 2004 Feb; 7(2):91-5. PubMed ID: 15057645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host directed therapies: COVID-19 and beyond.
    Tripathi D; Sodani M; Gupta PK; Kulkarni S
    Curr Res Pharmacol Drug Discov; 2021; 2():100058. PubMed ID: 34870156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviruses and other latent viruses: the deadliest of pathogens are not necessarily the best candidates for bioterrorism.
    Salgado CD; Kilby JM
    J S C Med Assoc; 2009 Jun; 105(3):104-6. PubMed ID: 19639767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repurposing: a new front in the war against Staphylococcus aureus.
    Das S; Dasgupta A; Chopra S
    Future Microbiol; 2016 Aug; 11():1091-9. PubMed ID: 27494302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
    Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
    Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives to antibiotics: chemical and physical antimicrobial interventions and foodborne pathogen response.
    Ricke SC; Kundinger MM; Miller DR; Keeton JT
    Poult Sci; 2005 Apr; 84(4):667-75. PubMed ID: 15844827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omics of antimicrobials and antimicrobial resistance.
    Chernov VM; Chernova OA; Mouzykantov AA; Lopukhov LL; Aminov RI
    Expert Opin Drug Discov; 2019 May; 14(5):455-468. PubMed ID: 30884978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19.
    Das R; Kotra K; Singh P; Loh B; Leptihn S; Bajpai U
    Infect Dis Ther; 2022 Feb; 11(1):53-78. PubMed ID: 34807451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.
    Lucien MAB; Canarie MF; Kilgore PE; Jean-Denis G; Fénélon N; Pierre M; Cerpa M; Joseph GA; Maki G; Zervos MJ; Dely P; Boncy J; Sati H; Rio AD; Ramon-Pardo P
    Int J Infect Dis; 2021 Mar; 104():250-254. PubMed ID: 33434666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
    Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
    Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of antimicrobial resistance: another casualty of the COVID-19 pandemic?
    Razzaque MS
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):967-971. PubMed ID: 33322965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.